Cite
Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial
MLA
van Veldhuisen, Dirk J., and John J. V. McMurray. “Are Erythropoietin Stimulating Proteins Safe and Efficacious in Heart Failure? Why We Need an Adequately Powered Randomised Outcome Trial.” European Journal of Heart Failure, vol. 9, no. 2, Feb. 2007, pp. 110–12. EBSCOhost, https://doi.org/10.1016/j.ejheart.2007.01.004.
APA
van Veldhuisen, D. J., & McMurray, J. J. V. (2007). Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. European Journal of Heart Failure, 9(2), 110–112. https://doi.org/10.1016/j.ejheart.2007.01.004
Chicago
van Veldhuisen, Dirk J., and John J.V. McMurray. 2007. “Are Erythropoietin Stimulating Proteins Safe and Efficacious in Heart Failure? Why We Need an Adequately Powered Randomised Outcome Trial.” European Journal of Heart Failure 9 (2): 110–12. doi:10.1016/j.ejheart.2007.01.004.